Breast Cancer Working Group Final Report

• model building process
• clinical trial design

Discussion of Breast Cancer Working Group

• analysis of process
• identification of markers/technologies and interactions with industry

Current NCI industry assistance mechanisms

How can the NCI facilitate evaluation of promising technologies/markers?

• identification of companies
• infrastructure needs

Next set of critical clinical questions/action plan